THYROID FUNCTION IN HIV PATIENTS ATTENDING TO A TERTIARY CARE HOSPITAL

Dr A Swamy, Dr B Purushotham Rao

Abstract


In this prospective study of 100 HIV infected patients at various stages of illness, thyroid function tests consisting of T3, T4,
and serum thyroid-stimulating hormone (TSH) are studied. The results analyzed and the correlation of abnormalities in
thyroid function tests with the CD4 count studied. All the cases included interrogated and examined. Out of the 100
patients studied, 60% were males, and 40% were females. The age group ranged from 20 years to above 50 years of age.
The CD4 count ranged from less than 100 to more than 500. In this study, 80% of the population had T4 levels between 5-
12.0, and 42% had TSH levels between 0.5 to 5, whereas 48% of the studied population had an increased TSH above 5. All
patients with CD4 count less than 100 had an increased TSH of above 5, and 94% of the patients with CD4 between 100-
200 had TSH above 5.
OBJECTIVES: To evaluate the thyroid function in patients infected with human immunodeficiency virus (HIV) and to
correlate the results with the CD4 count


Keywords


Thyroid function, Hiv, CD4 count

Full Text:

PDF

References


Sellmeyer D, Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev. 1996; 17:518–32.

Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM. Metabolic complications associated with antiretroviral therapy. Antiviral Res. 2001; 51:151–177

Jubault V, Penfornis A, Schillo F, et al. Sequential occurrence of thyroid autoantibodies and Grave’s disease after immune restoration in severely immune-compromised human immunodeficiency virus–1–infected patients. J Clin Endocrinol Metab.2000; 85:4254–7.

Grappin M, Piroth L, Verge`s B, et al. Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS.2000; 14:1070–2.

Beltran S, Lescure F-X, Desailloud R, et al. Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: a need for screening. Clin Infect Dis. 2003; 37:579–83

Madeddu G, Spanu A, Chessa F, et al. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy. Clin Endocrinol (Oxf). 2006;64:375–83

Calza L, Manfredi R, Chiodo F. Subclinical hypothyroidism in HIV infected patients receiving highly active antiretroviral therapy. J Acquir Immun Defic Syndr. 2002; 31:361–3

Pasupathi P, Manivannan P, Manivannan U, Mathiyalagan D. Thyroid Function, Cardiac Risk Assessment Profile, and Hematological Changes During HIV Infection and AIDS Patients. J Medicine. 2010; 11:131-136

Bongiviani M, Casana M, Tordato F, Tincati C, Cicconi P, Bini T, et al. Subclinical hypothyroidism in HIV-infected subjects. J Anti Chem. 2006; 58:1086-1089

Jain G, Devpura G, Gupta B S.Abnormalities in the Thyroid Function Tests as Surrogate Marker of Advancing HIV Infection in Infected Adults. JAPI 2009; 57(7):508-510

Brink A K, Mahéa C, Wateraa C, Lugadaa E, Gilksb, Whitworth J. Diarrhoea, CD4 Counts and Enteric Infections in a Community-Based Cohort of HIV-Infected Adults in Uganda. J Inf. 2002; 45:99–106

Van der Sande A B M, Van der Loeff S M F, Aveika A A, Sabally S, Togun T, Jaye A, et al. Body Mass Index at Time of HIV Diagnosis: A Strong and Independent Predictor of Survival. J Acquir Immune Defic Syndr. 2004; 37(2):1288-1294


Refbacks

  • There are currently no refbacks.